Visual Arrestin Antibodies

Santa Cruz Biotechnology delivers a wide array of Visual Arrestin monoclonal antibodies for investigating visual arrestin's function in phototransduction. Visual Arrestin monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Visual arrestin regulates photoreceptor cells and serves as a key component in the visual signaling pathway by binding to phosphorylated rhodopsin, which prevents further activation of the phototransduction cascade. The regulation of visual signaling through visual arrestin is fundamental for maintaining proper vision function. Disruptions in visual arrestin activity can result in various retinal disorders and vision impairments. Research focused on visual arrestin mechanisms continues to reveal new insights about vision-related diseases and potential treatments. Understanding visual arrestin's role in photoreceptor regulation advances knowledge about retinal function and disease progression. Visual arrestin research using specific molecular tools helps identify new therapeutic targets for vision disorders. Santa Cruz Biotechnology monoclonal antibodies for visual arrestin support researchers worldwide in advancing vision science and developing new treatments for retinal diseases.